▼Pregabalin for generalised anxiety disorder. Issue 2 (10th February 2010)

• Record Type: Journal Article
• Is Part Of: Drug and therapeutics bulletin. Volume 48:Issue 2(2010)
• Page Start: 19
• Page End: 22
• Publication Date: 2010-02-10
• Subjects: Drugs -- Periodicals; Therapeutics -- Periodicals; Pharmacology -- Periodicals; 615.5
• DOI: 10.1136/dtb.2009.10.0048
• Languages: English
• ISSNs: 1755-5248

Abstract

Abstract : Generalised anxiety disorder (GAD) is common, with a prevalence of around 4% among adults in the UK.1 The condition is characterised by chronic excessive anxiety and worry, in combination with a variety of psychological or somatic symptoms. It can be very distressing and disabling and, if left untreated, can be costly to both the individual and society.2 ▼Pregabalin (Lyrica – Pfizer) is a medicine licensed for GAD in adults.3 Here we review its role in the management of patients with the problem.